Kevin is currently focused on AxoSim’s NerveSim® platform. He has a PhD in Chemistry and has worked for more than a decade in the biotechnology field. With experience in antibody development, disease diagnostic testing, and live virus research, he has a deep understanding of the science behind the client’s needs.
Current role